"If PEB havent been paid as is the case with CMS, and boy, they have done a lot of tests for them, there may be some kind of a windfall once that is sorted out and CDY may get a bit of a boost as well"
Just looking at the September 4C. It discloses Customer Receipts from Sales as $2.01m and Consumer Health Sales as $1.55m. Could the difference ($0.46m) be for Licence Fees and Royalties?
CDY Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
